These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 6464157

  • 1. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB, Fagan DS, Meyer DR.
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [Abstract] [Full Text] [Related]

  • 2. Red cell ATP and 2,3-diphosphoglycerate concentrations as a function of dihydroxyacetone supplementation of CPD adenine.
    Moore GL, Ledford ME, Brummell MR.
    Vox Sang; 1981; 41(1):11-7. PubMed ID: 7324438
    [Abstract] [Full Text] [Related]

  • 3. Blood storage XXIV: red blood cell 2,3-DPG and ATP maintenance for six weeks in CPD-adenine with higher phosphate, pyruvate, and dihydroxyacetone.
    Dawson RB.
    Transfusion; 1977; 17(3):242-7. PubMed ID: 867465
    [Abstract] [Full Text] [Related]

  • 4. Blood preservation. XXXIV. DHA maintains 2,3-DPG and its adverse effect on ATP is reversed with extra phosphate.
    Dawson RB, Meyer DR, Hedian KA, Hershey RT, Myers CS.
    Transfusion; 1980; 20(3):311-5. PubMed ID: 7385325
    [Abstract] [Full Text] [Related]

  • 5. Blood preservation 35. Red cell 2,3-DPG and ATP maintained by DHA-ascorbate-phosphate.
    Dawson RB, Hershey RT, Myers CS, Miller RM.
    Transfusion; 1981; 21(2):219-23. PubMed ID: 7222204
    [Abstract] [Full Text] [Related]

  • 6. Blood preservation using metabolic regulators and nutrients: XXI. Further studies on pyruvate and DHA (dihydroxyacetone).
    Dawson RB.
    Transfusion; 1976; 16(5):446-9. PubMed ID: 982536
    [Abstract] [Full Text] [Related]

  • 7. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G, Morse EE, Katz AJ, Kahn RA, Dende D, Swatman L, Staggs SD.
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [Abstract] [Full Text] [Related]

  • 8. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G, Dende D.
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [Abstract] [Full Text] [Related]

  • 9. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
    Valeri CR, Valeri DA, Gray A, Melaragno A, Dennis RC, Emerson CP.
    Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
    [No Abstract] [Full Text] [Related]

  • 10. Rejuvenation of erythrocytes preserved with AS-1 and AS-3.
    Brecher ME, Zylstra-Halling VW, Pineda AA.
    Am J Clin Pathol; 1991 Dec; 96(6):767-9. PubMed ID: 1746494
    [Abstract] [Full Text] [Related]

  • 11. The effect of ascorbate and dihydroxyacetone on the 2,3-diphosphoglycerate and ATP levels of stored human red cells.
    Wood L, Beutler E.
    Transfusion; 1974 Dec; 14(3):272-7. PubMed ID: 4835952
    [No Abstract] [Full Text] [Related]

  • 12. Reduction of blood oxygen affinity in dogs by infusion of glycolytic intermediates.
    Bristow JD, Metcalfe J, Krall MA, Welch JE, Black JA, Dhindsa DS.
    J Appl Physiol Respir Environ Exerc Physiol; 1977 Jul; 43(1):102-6. PubMed ID: 893250
    [No Abstract] [Full Text] [Related]

  • 13. Blood storage XXV: Ascorbic acid (vitamin C) and dihydroxyacetone (DHA) maintenance of 2,3-DPG for six weeks in CPD-adenine.
    Dawson RB.
    Transfusion; 1977 Jul; 17(3):248-54. PubMed ID: 867466
    [No Abstract] [Full Text] [Related]

  • 14. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA, Arun P, Gayathri NS, Dhanya CR, Indu AR.
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Xanthone additives for blood storage that maintain its potential for oxygen delivery. I. 2-Hydroxyethoxy- and 2-ethoxy-6-(5-tetrazoyl) xanthones in citrate-phosphate-dextrose-adenine (CPDA-1) blood.
    Paterson RA, Dawson J, Hyde RM, Livingstone DJ, Parry ES, Nash S, Boyce IM.
    Transfusion; 1988 Nov; 28(1):34-7. PubMed ID: 3341063
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Acid-citrate-dextrose-phosphoenolpyruvate medium as a rejuvenant for blood storage.
    Hamasaki N, Hirota-Chigita C.
    Transfusion; 1983 Nov; 23(1):1-7. PubMed ID: 6829052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.